98%
921
2 minutes
20
Glaucoma is the leading cause of irreversible blindness worldwide. Currently, artificial intelligence (AI) technology combined with optical coherence tomography (OCT) and visual field testing is widely used for glaucoma progression prediction. However, the lack of labeled patient data and the ambiguity of structural differences in glaucoma remain major research bottlenecks. To address this, this paper proposes a glaucoma progression prediction method based on a semi-supervised reinforcement learning (SSRL) framework. In the SSRL framework, we design a key experience filtering strategy (KEFS) that prioritizes high-value training samples to enhance the model's generalization ability and optimize the quality of pseudo-labels. Additionally, an entropy regularization technique is introduced to encourage high-entropy distributions, preventing the model from prematurely converging to specific decisions and improving its ability to explore unlabeled data. To adapt the classifier and the pseudo-label generator within the SSRL framework, we innovatively propose the IncepMambaNet multi-scale network. This network integrates the visual state space (VSS) module from the VMamba model with traditional CNN structures, designing a four-branch IncepMamba module that leverages the strengths of both approaches. Experimental results demonstrate that compared to traditional supervised learning methods, our SSRL model effectively improves the performance of various state-of-the-art (SOTA) supervised classification networks. Furthermore, compared to various SOTA classification networks, IncepMambaNet achieves leading performance in three key metrics-macro-F1, F2-score, and AUC-by 0.8%, 8.8%, and 0.9%, respectively, showcasing outstanding feature capture capability and generalization performance. Ablation studies further confirm that the multi-branch structure and channel reordering operations play a crucial role in enhancing model performance.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12539-025-00739-x | DOI Listing |
Cureus
August 2025
Acute Medicine, Southend University Hospital, Mid and South Essex NHS Foundation Trust, Southend-on-Sea, GBR.
Adenocarcinoma of the lung is the most common type of lung cancer and is classified as one of the non-small cell lung cancers. It typically arises in the peripheral regions of the lungs, affecting the dense glandular tissues. Most patients diagnosed with pulmonary adenocarcinoma are current or former smokers and present with nonspecific respiratory symptoms such as a persistent cough and shortness of breath.
View Article and Find Full Text PDFZhonghua Yan Ke Za Zhi
September 2025
Aier Glaucoma Institute, Hunan Engineering Research Center for Glaucoma with Artificial Intelligence in Diagnosis and Application of New Materials, Changsha Aier Eye Hospital, Changsha 410015, China.
As the world's leading irreversible blinding eye disease, glaucoma is predominantly managed with pharmaceutical interventions in clinical practice. However, long-term use of traditional eye drops containing preservatives (e.g.
View Article and Find Full Text PDFVestn Oftalmol
September 2025
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Primary open-angle glaucoma (POAG) is characterized by chronic progressive damage to the retinal ganglion cell layer (GCL) and their axons, leading to gradual visual function loss. Currently, the gold standards for structural and functional assessment of the retina in glaucoma are static automated perimetry (SAP) and optical coherence tomography (OCT). However, in clinical practice, data from SAP and OCT may be insufficient to reliably determine the stage of glaucomatous optic neuropathy, monitor its progression, or differentiate it from other causes of visual dysfunction.
View Article and Find Full Text PDFVestn Oftalmol
September 2025
OOO Diagnosticheskij tsentr Zreniye, Saint Petersburg, Russia.
Objective: This study evaluated the effect of sequential therapy with different dosages of Mexidol on the stabilization of glaucomatous optic neuropathy (GON) in patients with primary open-angle glaucoma (POAG).
Material And Methods: The study included 80 patients (160 eyes) with stage II and III POAG, randomized into three groups comparable by age, gender, and distribution of glaucoma stage. All patients received sequential therapy with Mexidol (14 days parenterally followed by 90 days orally).
Ophthalmol Sci
July 2025
Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Purpose: To investigate global longitudinal structure-function (SF) relationships between macular ganglion cell complex (GCC) thickness and central visual field (VF) mean deviation (MD) rates of change using a Bayesian joint bivariate longitudinal model.
Design: Prospective cohort study.
Participants: One hundred seventeen eyes from 117 patients with glaucoma with central damage or moderate to advanced glaucoma were included.